Stimulation of Platelet-derived Growth Factor Receptor β (PDGFRβ) Activates ADAM17 and Promotes Metalloproteinase-dependent Cross-talk between the PDGFRβ and Epidermal Growth Factor Receptor (EGFR) Signaling Pathways
Karen Mendelson(Hospital for Special Surgery), Carl Blobel(Hospital for Special Surgery)
Cited by 52
Related Papers
Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand–dependent terminal keratinocyte differentiation
|The Journal of Experimental Medicine|2012|186
iRhom2 controls the substrate selectivity of stimulated ADAM17-dependent ectodomain shedding
|Proceedings of the National Academy of Sciences|2013|165
iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling
|Proceedings of the National Academy of Sciences|2015|162
Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17
|Nature Communications|2011|154
Pathological Neovascularization Is Reduced by Inactivation of ADAM17 in Endothelial Cells but Not in Pericytes
|Circulation Research|2010|143